Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: SIHUAN PHARM(00460) the Revenue is 670.1 M (+6.83%);the EBIT is 124.28 M (+10.19%);the EPS is 0.0144 (+136.5%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.67B6.83%
----
----
EBIT
0.12B10.19%
----
----
EPS
0.0144136.45%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf